Abstract
Background: Vertical transmission of Zika Virus (ZIKV) can be associated with several clinical features in newborn infants. The goal of the present review was to analyze the current state of knowledge regarding clinical repercussions following perinatal exposure to ZIKV in children up to 3 years of age.
Methods: A systematic review of published studies was carried out, without the restriction of language or date of publication, identified in the databases PubMed, Virtual Health Library (BVS), Scopus, and Web of Science and the catalog for CAPES theses and dissertations. According to the proposed flowchart, the bibliographic search resulted in 1,563 papers. Of these, according to the eligibility criteria, 70 were selected for systematic review; all were published between 2016 and 2021.
Results: Regarding clinical findings, 19 papers evaluated clinical imaging alterations, 21 ophthalmic manifestations, and 39 evaluated the central nervous system; of these, 15 analyzed neuro-psychomotor development. The remainder evaluated audiological (n = 14), nutritional (n = 14), orthopedic (n = 7), cardiorespiratory (n = 5), genitourinary (n = 3) or endocrinological (n = 1) manifestations.
Conclusion: It is critical for studies to continue monitoring children with antenatal ZIKV exposure as they grow, given the unknown long-term repercussions of ZIKV and the recognized postnatal complications of this infection during pregnancy. Broader descriptions of observed clinical findings are also important in order to characterize the entire spectrum of disease in children.
Systematic Review Registration: PROSPERO REGISTER: CRD42020205947.
Background
Zika virus (ZIKV) was first reported in East Africa in the 1950 s. In 2007, global attention emerged following an outbreak in Micronesia, and in the following decade, on the island of Yap, in the French Polynesia. The virus spread widely in other Pacific islands over the years, before emerging as a widespread epidemic throughout Latin America (1, 2). In 2015, with the arrival of ZIKV in Brazil, the first studies reported descriptions of women with fever and rash during pregnancy and a possible relationship with congenital microcephaly (3–5). The hypothetical relationship between ZIKV infection in pregnancy and subsequent abnormal newborn findings arose after a very large increase in microcephaly cases was observed in Brazil a few months after ZIKV circulation was identified in the country. Due to its catastrophic repercussions to newbor infants, the World Health Organization (WHO) declared Zika virus a Public Health Emergency in 2016. Gradually over 2017, ZIKV cases declined consistently across the world, although certain tropical areas of the globe became endemic for ZIKV infection, including Central and South America, the Caribbean, and southern Asia. Outbreaks were reported in 2018 in India and Angola, and in France, a locally acquired infection was reported in 2019. One of the driving forces behind the rapid ZIKV epidemic spread was global warming and population mobility which greatly contributed to an increase in the environmental span of Aedes sp. mosquitoes. The possibility of new outbreaks lingers, particularly since arboviral outbreaks are notoriously cyclical. In addition, ZIKV, unlike other arboviral infections, can be transmitted by sexual contact. Therefore, pregnant women may be infected by partners who traveled to endemic areas. Therefore, travel histories should include not only the pregnant patient but their partners as well. Since the virus can persist for extended periods of time in semen, pregnant women could be at risk for infection weeks to months following partner travel to endemic areas.
The fact that ZIKV has a very similar genomic structure to dengue viruses 1–4, has important diagnostic implications. Arboviral flaviviruses in the same family as ZIKV include yellow fever, Japanese encephalitis, and West Nile viruses. Hepatitis C virus, another flavivirus, also shares some genomic similarities with ZIKV, which carries potential antiviral treatment implications. Over time ZIKV evolved from the African lineage to the Asian lineage (there is 90% homology between strains), and potentially acquired higher teratogenic potential during the process. The Asian strain of ZIKV was responsible for the recent pandemic.
Although ZIKV infection is generally asymptomatic, 20% of patients develop mild symptoms. The clinical features resemble that of rubella virus infection. If symptoms occur, they are present 7–10 days following exposure. Most prominent findings are a maculopapular pruritic rash, arthralgia and conjunctival erythema. Fever is rare and, if present, low grade. Rash, pruritus, conjunctival hyperemia, no fever, no petechiae and no anorexia are used as a ZIKV case definition in endemic settings, where dengue and chikungunya are also prevalent. ZIKV infection is typically self-limited with resolution of symptoms within 1 week. Most patients recover without complications, including pregnant women.The absence of clinical symptoms of ZIKV during pregnancy, however, does not indicate no risk of clinical repercussions to infants. Women with asymptomatic disease can deliver infants with microcephaly. Virus load during maternal infection, disease severity and frequency of symptoms, as well as prior dengue immunity have not been predictive of infant outcomes at birth.
The Centers for Disease Control and Prevention (CDC) coined the term Congenital Zika Syndrome (CZS) which refers to infants most severely affected by antenatal ZIKV exposure. Nevertheless, many studies demonstrated a spectrum of clinical manifestations in children ranging from absent findings to severe microcephaly. CZS is defined as a constellation of findings at birth including: (1) severe microcephaly (>3 SD below the mean for gestational age and gender); (2) brain abnormalities (subcortical calcifications, ventriculomegaly, cortical thinning, gyral pattern anomalies, hypoplasia of the cerebellum, or corpus callosum anomalies); (3) ocular findings; (4) congenital contractures, also known as arthrogryposis; and (5) neurologic impairment. Microcephaly rates range from 3 to 7% in prospective studies. Most common abnormalities include cerebral calcifications, cortical developmental malformations (lissencephaly, pachygyria, agyria), ventriculomegaly due to brain atrophy, posterior fossa alterations including brainstem or cerebellar hypoplasia, corpus callosum abnormalities, enlarged extra-axial cerebrospinal fluid spaces, and enlarged cisterna magna. Ophthalmologic and sensorineural hearing loss have been reported in 7 and 12% of infants, respectively, followed since the time of maternal infection. They prevail in children with other CNS findings but can also be an isolated finding. Eye manifestations include abnormalities of the retinal pigment epithelium of the macula, optic nerve hypoplasia, chorioretinal atrophy; other abnormalities are colobomas and microphthalmia. Abnormal visual function is identifiable in early infancy among affected children. Eye abnormalities do not tend to progress. Another interesting observation, which highlights some similarities with congenital rubella syndrome is that 10% of children with in utero ZIKV exposure had congenital heart defects in prospective studies. Longer term outcome studies demonstrated that 15% of children may have severe neurodevelopmental problems and sensorineural abnormalities by 3 years of age. Conversely, not all children with abnormalities at birth have later neurodevelopmental repercussions. In the same way, infants found to be normal at birth following maternal infection during pregnancy might have abnormal developmental outcomes years later. Studies demonstrated that close to 1/3 of infants with antenatal ZIKV exposure have below average neurodevelopment or abnormal eye or hearing findings, Secondary microcephaly, which is microcephaly occurring after birth, as well as a higher rate of ASD have been noted in children exposed to antenatal ZIKV, underscoring that long term follow-up is necessary.
ZIKV has been shown to cross the placenta and infect placental macrophages. This disrupts neural progenitor cell evolution, leading to microcephaly in animal models. Maternal infection earlier in pregnancy leads to more severe fetal outcomes. CNS malformations are more common with first and second trimesters infections. Late term fetal demise can occur due to placental vascular involvement with focal necrotic vasculitis and placental failure. In summary, adverse outcomes due to ZIKV infection have been described across all trimesters of pregnancy. Miscarriages and fetal growth restriction have also been described. The virus can induce CNS calcifications and bone fusion; craniosynostosis may be present in congenital ZIKV infection.
Congenital ZIKV infection has become widely recognized since its original description. Microcephaly is defined as a head circumference of <2 or more standard deviations from the benchmark for gender, age, or gestational age, per the Brazilian Ministry of Health (6). The spectrum of congenital disabilities linked to ZIKV besides microcephaly, such as eye alterations, craniofacial disproportion, and joint and limb deformities, characterize Congenital ZIKV Syndrome (CZS) (7). As previously discussed, clinical alterations and subsequent developmental delays are widely described in babies born without microcephaly, in some cases infants with no stigmata of CZS (8–12). However, there is very little information about future clinical implications of antenatal ZIKV infection in the long term, and this is the target of several studies.
Methods
A systematic review was undertaken to analyze the current state of knowledge regarding repercussions of vertical exposure to ZIKV on child health. The search for pertinent studies was carried out using databases of the Virtual Health Library (BVS), MEDLINE via PubMed, Web of Science, and Scopus via Capes journals portal, CAPES thesis, and dissertation catalogs.
This comprehensive review was undertaken to address the following question: “What is the impact of vertical exposure to ZIKV on clinical, nutritional, and neurodevelopmental aspects in children up to 3 years of age?” This question was formulated per the PICO acronym. The description of this systematic review was based on the Preferred Reporting Items for Systematic Reviews (PRISMA) guidelines (13). Thus, the following steps were developed: identification of the research question, literature search, data evaluation, analysis of results, and presentation of the review (Figure 1).
Figure 1
The following descriptors were used for the search strategy: “Zika Virus,” “Zika Virus Infection” as search terms, along with “Zika Virus Infection/complications” or the specific clinical outcome designations: “neurogenic bladder,” “urinary bladder,” “Nutritional status,” “nutrition,” “Anthropometry,” “Hearing,” “Orthopedics,” “arthrogryposis,” “vision,” “Neurologic disease,” “Neurologic Manifestations,” “Gastrointestinal Diseases,” “Cardiovascular disease,” “Cardiovascular Abnormalities,” “neurodevelopment.” Boolean operators AND, OR, and NOT were used to relate the blocks to each other, to add at least one word from each block. This systematic review was registered and approved by the PROSPERO systematic review protocol registry database under registration number CRD42020205947.
Two independent researchers carried out the search process, which ended in January 2021, with no limits for the period of publication or language restrictions. The bibliographic search resulted in 1,563 papers. Of these, 159 were selected for full-text reading because they evaluated clinical manifestations in cohorts of children with antenatal ZIKV exposure. After extensive selection, 89 papers were excluded because they addressed topics that were not relevant to the present work, leaving 70 studies eligible for this paper, as seen in Figure 1. Eligibility criteria for manuscript selection included full text studies that reported clinical findings/outcomes in cohorts of children with documented antenatal ZIKV exposure. As such, incomplete manuscripts/abstracts, review papers, studies in fetuses, animal studies, in vitro studies, studies in adults only, and qualitative studies were excluded. In addition, manuscripts referenced in papers selected for this study were also investigated, however no further papers were identified. The selected publications were compared in regards to the following parameters: year of publication, study location, sample size, mean age of participants, design type, eligibility criteria, exposure period, presence of a control group, symptoms, controlled confounders in the analysis, study limitations, and main results.
Results
Seventy papers published from 2016 to 2021 were selected following the search. Of these, most were conducted in Brazil (n = 58), followed by Colombia (n = 4), the U.S. (n = 3), Spain (n = 2), French Guiana (n = 1), Mexico (n = 1), and the French Polynesia (n = 1) (Figure 2). The sample size ranged from 1 to 5,673 participants. The population studied ranged in age from 0 days to 48 months, with 9 studies not reporting the participant age range (Table 1).
Figure 2
Table 1
| References | Country | Sample size (n) | Age of follow-up |
|---|---|---|---|
| Almeida et al. (14) | Brazil | 100 | Not provided |
| Alves et al. (15) | Brazil | 24 | 19.9 (18– 24 months) |
| Aragao et al. (16) | Brazil | 12 | 135 days |
| Bertolli et al. (17) | Brazil | 120 | 24 months |
| Brasil et al. (5) | Brazil | 207 | Birth |
| Carvalho et al. (18) | Brazil | 82 | 13, 2 months |
| Carvalho et al. (19) | Brazil | 37 | 2, 6 (1–5 months) |
| Carvalho-Sauer et al. (20) | Brazil | 393 | Birth |
| Contreras-Capetillo et al. (21) | Mexico | 3 | Newborns |
| Costa Monteiro et al. (22) | Brazil | 69 | 13 months |
| Costa Monteiro et al. (23) | Brazil | 22 | 9 months |
| Cranston et al. (24) | Brazil | 296 | 0 −48 months |
| de Fatima Vasco Aragao et al. (25) | Brazil | 23 | 1 month |
| de Paula Freitas et al. (26) | Brazil | 29 | 1–6 months |
| de Paula Guimarães et al. (27) | Brazil | 69 | Not provided |
| dos Santos et al. (28) | Brazil | 21 | Not provided |
| dos Santos et al. (29) | Brazil | 65 | 15 months |
| Fandiño-Cárdenas et al. (30) | Colombia | 66 | Exposed: 3.5 months; Control: 3 months |
| Felix et al. (31) | French Guiana | 2 | 2–4 months |
| Ferreira et al. (32) | Brazil | 34 | 21 months |
| França et al. (33) | Brazil | 24 | 20.5 months |
| Jucá et al. (34) | Brazil | 115 | Not provided |
| Kanda et al. (35) | Brazil | 23 | 8.3 months |
| C Lage et al. (36) | Brazil | 102 | 4.1 months |
| Leal et al. (37) | Brazil | 70 | 0–10 months |
| Leal et al. (38) | Brazil | 9 | 4 (2–7 months) |
| Leal et al. (39) | Brazil | 1 | Birth−1 month |
| Leal et al. (40) | Brazil | 57 | 22.9 months |
| Leite et al. (41) | Brazil | 45 | 10 months |
| Linden et al. (42) | Brazil | 3 | 7–19 months |
| Marques Abramov et al. (43) | Brazil | 19 | Not provided |
| Melo et al. (44) | Brazil | 59 | 14.7 months |
| Meneses et al. (45) | Brazil | 87 | Birth |
| Lopes Moreira et al. (10) | Brazil | 104 | 2–18 months |
| Moura da Silva et al. (46) | Brazil | 48 | 1–8 months |
| Mulkey et al. (47) | Colombia | 70 | Birth−18 months |
| Nielsen-Saines et al. (11) | Brazil | 216 | 18 months |
| Oliveira-Filho et al. (48) | Brazil | 27 | 101 days |
| Orofino et al. (49) | Brazil | 186 | 97 (1–376 days) |
| Ospina et al. (50) | Colombia | 5,673 | Birth |
| Pacheco et al. (51) | Colombia | 60 | 20–30 months |
| Peçanha et al. (52) | Brazil | 84 | 1st Moment: 9.7 months 2nd Moment: 15.3 months |
| Petribu et al. (53) | Brazil | 37 | 1st Moment: 1 to 138 days (median of 11.5 days) 2nd Moment: 105 to 509 days (median of 415 days) |
| Pinato et al. (54) | Brazil | 136 | 5–24 months |
| Pone (55) | Brazil | 106 | Not provided |
| Pool et al. (56) | Brazil | 110 | Newborn period |
| Rajapakse et al. (57) | United States | 4 | 3–10 days of life; 1–86 days |
| Rice et al. (58) | United States | 1,450 | ≥12 months |
| Rocha et al. (59) | Brazil | 174 | 9 months |
| Roma et al. (60) | Brazil | 20 | Newborns |
| Santana et al. (61) | Brazil | 18 | 21.5 months |
| Satterfield-Nash et al. (62) | Brazil | 19 | 22 months |
| Soares et al. (63) | Brazil | 115 | Birth – 3 months |
| Soriano-Arandes et al. (64) | Spain | 143 | 1, 4, 9, 12, 18, and 24 months |
| Subissi et al. (65) | French Polynesia | 123 | 23 months |
| Sulleiro et al. (66) | Spain | 1 | 24 months |
| Trigueiro et al. (67) | Brazil | 20 | Not provided |
| Tsui et al. (68) | Brazil | 224 | 44 days (12–99 days) |
| van der Linden et al. (69) | Brazil | 21 | 16–30 months (mean 16 months at the time of the last examination) |
| van der Linden et al. (70) | Brazil | 13 | 05–12 months |
| van der Linden et al. (71) | Brazil | 7 | Not provided |
| de Vasconcelos et al. (72) | Brazil | 22 | 36 months |
| Ventura et al. (73) | Brazil | 40 | 2.2 months |
| Ventura et al. (73) | Brazil | 32 | 5.7 (4–7 months) |
| Ventura et al. (74) | Brazil | 204 | Exposed: 8.5 months (6–13 months) Controls: 8.4 months (5–12 months) |
| Veras Gonçalves et al. (75) | Brazil | 30 | 41 months |
| Verçosa et al. (76) | Brazil | 70 | 3 months |
| Walker et al. (77) | United States | 95 | Newborn period |
| Zin et al. (12) | Brazil | 112 | Not provided |
| Zin et al. (78) | Brazil | 173 | 3–6 months |
Year of publication, origin, sample size and age of participants of selected studies, 2016–2021.
Most studies were (n = 37) descriptive in design, such as case series or case reports, followed by cross-sectional studies (n = 17), cohort studies (n = 14), and case-control studies (n = 2). Information on study limitations was described in 40 studies; the most prevalent limitation was the limited sample size, lack of a control group, type or lack of laboratory confirmation for ZIKV, loss to follow-up, and use of secondary data for analysis. Details on duration of follow-up, sample size and study design are shown in Figure 3.
Figure 3
Concerning clinical findings, 19 papers evaluated clinical imaging alterations, 21 ophthalmic manifestations, 39 the central nervous system, including 15 which evaluated neuro-psychomotor development. Additional studies included audiological (n = 14), nutritional (n = 14), orthopedic (n = 7), cardiorespiratory (n = 5), genitourinary (n = 3) or endocrinological (n = 1) manifestations. It is noteworthy that some articles described more than one organ system and multiple clinical findings (Table 2).
Table 2
| References | Study design | Clinical abnormalities | Developmental screening test |
|---|---|---|---|
| Almeida et al. (14) | Case series | Hearing abnormalities; Eye abnormalities | – |
| Alves et al. (15) | Case series | Neurodevelopmental delays | Denver Development Screening Test II |
| Aragao et al. (16) | Case series | Joint and limb deformities | – |
| Bertolli et al. (17) | Cohort | Neurodevelopmental delays | ASQ 3 |
| Brasil et al. (5) | Cohort | Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Carvalho et al. (18) | Case series | Neurological abnormalities; Neurodevelopmental delays; Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Carvalho et al. (19) | Case series | Neurological abnormalities | – |
| Carvalho-Sauer et al. (20) | Cross-sectional | Growth and nutrition | – |
| Contreras-Capetillo et al. (21) | Case series | Joint and limb deformities; Growth and nutrition; Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Costa Monteiro et al. (22) | Case series | Genito-urinary abnormalities (Criptorquidia, Neurogenic bladder) | – |
| Costa Monteiro et al. (23) | Case series | Genito-urinary abnormalities (Criptorquidia, Neurogenic bladder) | – |
| Cranston et al. (24) | Cohort | Cardiological abnormalities; Hearing abnormalities; Eye abnormalities; Neurological abnormalities; Growth and nutrition; Neurodevelopmental delays | Bayley III |
| de Fatima Vasco Aragao et al. (25) | Retrospective case series | Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| de Paula Freitas et al. (26) | Case series | Eye abnormalities | – |
| de Paula Guimarães et al. (27) | Case series | Hearing abnormalities; Eye abnormalities; Neurological abnormalities | – |
| dos Santos et al. (28) | Descriptive Longitudinal Study | Growth and nutrition | – |
| dos Santos et al. (29) | Descriptive Longitudinal Study | Growth and nutrition | – |
| Fandiño-Cárdenas et al. (30) | Cohort | Hearing abnormalities | – |
| Felix et al. (31) | Case report | Neurological abnormalities | – |
| Ferreira et al. (32) | Cross-sectional | Neurodevelopmental delays | Common Brief ICF Core Set for CP |
| França et al. (33) | Cross-sectional | Growth and nutrition; Neurodevelopmental delays | Bayley III |
| Jucá et al. (34) | Case series | Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Kanda et al. (35) | Cross-sectional | Neurological abnormalities | – |
| C Lage et al. (36) | Cross-sectional | Joint and limb deformities; Hearing abnormalities; Eye abnormalities; Neurological abnormalities | – |
| Leal et al. (37) | Case series | Hearing abnormalities | – |
| Leal et al. (38) | Case series | Gastrointestinal/pulmonary abnormalities | – |
| Leal et al. (39) | Case report | Hearing abnormalities | – |
| Leal et al. (40) | Cross-sectional study nested in a cohort | Adenoid hypertroph | – |
| Leite et al. (41) | Cross-sectional | Hearing abnormalities | – |
| Linden et al. (42) | Case series | Joint and limb deformities; Neurological abnormalities | – |
| Marques Abramov et al. (43) | Cross-sectional | Hearing abnormalities | – |
| Melo et al. (44) | Cross-sectional | Neurodevelopmental delays | Not provided |
| Meneses et al. (45) | Case series | Eye abnormalities; Neurological abnormalities; Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations); Gastrointestinal/pulmonary abnormalities | – |
| Lopes Moreira et al. (10) | Cohort | Neurodevelopmental delays | Bayley III |
| Moura da Silva et al. (46) | Case series | Gastrointestinal/pulmonary abnormalities; Joint and limb deformities; Neurological abnormalities; Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Mulkey et al. (47) | Cohort | Neurodevelopmental delays | Warner Initial Developmental Evaluation of Adaptive and Functio-l Skills (WIDEA) and the Alberta Infant Motor Scale (AIMS) |
| Nielsen-Saines et al. (11) | Cohort | Hearing abnormalities; Neurodevelopmental delays | Bayley III |
| Oliveira-Filho et al. (48) | Cohort | Gastrointestinal/pulmonary abnormalities; Neurological abnormalities; Growth and nutrition; Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Orofino et al. (49) | Cross-sectional | Cardiological abnormalities | – |
| Ospina et al. (50) | Retrospective cohort | Eye abnormalities; Growth and nutrition; Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Pacheco et al. (51) | Descriptive study | Hearing abnormalities; Eye abnormalities; Neurological abnormalities | – |
| Peçanha et al. (52) | Case series | Neurodevelopmental delays | Bayley III |
| Petribu et al. (53) | Case series | Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Pinato et al. (54) | Cross-sectional | Neurological abnormalities | – |
| Pone (55) | Cross-sectional | Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Pool et al. (56) | Retrospective cohort | Hearing abnormalities; Eye abnormalities; Neurological abnormalities; Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Rajapakse et al. (57) | Case series | Joint and limb deformities; Gastrointestinal/pulmonary abnormalities | – |
| Rice et al. (58) | Descriptive study | Neurodevelopmental delays | Not provided |
| Rocha et al. (59) | Case-control | Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Roma et al. (60) | Case series | Hearing abnormalities; Eye abnormalities; Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Santana et al. (61) | Case series | Gastrointestinal/pulmonary abnormalities; Cardiological abnormalities; Eye abnormalities; Neurological abnormalities; Neurodevelopmental delays; Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | Not provided |
| Satterfield-Nash et al. (62) | Case series | Hearing abnormalities; Neurological abnormalities; Neurodevelopmental delays | ASQ 3 |
| Soares et al. (63) | Cohort | Growth and nutrition | – |
| Soriano-Arandes et al. (64) | Cohort | Hearing abnormalities; Neurological abnormalities | – |
| Subissi et al. (65) | Case-control | Neurodevelopmental delays | Not provided |
| Sulleiro et al. (66) | Case report | Neurological abnormalities; Growth and nutrition | – |
| Trigueiro et al. (67) | Cross-sectional | Eye abnormalities | – |
| Tsui et al. (68) | Case series | Eye abnormalities | – |
| van der Linden et al. (69) | Descriptive study | Neurological abnormalities | – |
| van der Linden et al. (70) | Case series | Neurological abnormalities; Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| van der Linden et al. (71) | Cohort | Neurological abnormalities | – |
| de Vasconcelos et al. (72) | Case series | Genito-urinary abnormalities (Cryptorchidism/Neurogenic bladder) | – |
| Ventura et al. (73) | Cross-sectional | Eye abnormalities | – |
| Ventura et al. (73) | Cross-sectional | Eye abnormalities | – |
| Ventura et al. (74) | Cross-sectional | Eye abnormalities; Neurological abnormalities | – |
| Veras Gonçalves et al. (75) | Case series | Eye abnormalities; Endocrine disfunction | – |
| Verçosa et al. (76) | Case series | Eye abnormalities | – |
| Walker et al. (77) | Retrospective cohort | Eye abnormalities; Neurological abnormalities; Cerebral abnormalities (Microcephaly, Calcification, Hydrocephaly, Cerebral atrophy, Cerebellar alterations) | – |
| Zin et al. (12) | Case series | Joint and limb deformities; Eye abnormalities; Neurological abnormalities | – |
| Zin et al. (78) | Cross-sectional | Hearing abnormalities | – |
Study design, clinical abnormalities and development screening test, 2016–2021.
The most prevalent clinical imaging abnormalities of the central nervous system included microcephaly, ventriculomegaly, cortical malformations, mega cisterna magna, hydrocephalus, cerebellum or brain stem hypoplasia, and cerebral calcifications, especially at the junction between the cortical and subcortical white matter (16, 18, 21, 25, 34, 45, 46, 48, 50, 53, 56, 59–61, 75, 77). One manuscript also reported a decline in head circumference growth (70). Regarding abdominal imaging, there were no characteristic abnormalities identified in ZIKV exposed children that differed from descriptions in the general population. Imaging results were normal in 95.3% of 106 children who underwent abdominal ultrasound (55). Of five patients with abnormal abdominal ultrasounds, one (16.6%) had a splenic cyst, one (16.6%) had a diaphragmatic eventration, one (16.6%) had biliary lithiasis, one (16.6%) had multi-cystic dysplastic kidney, and two (33.4%) had a dilated renal pelvis. The prevalence of these alterations was 1.9% for renal pelvis dilatation and 0.9% for other abnormalities (55).
All the papers that evaluated the central nervous system found neurological alterations, and the main ones were seizure, epilepsy, irritability, pyramidal syndrome, sleep disorders, and hyperexcitability (5, 12, 18, 19, 27, 31, 35, 36, 42, 45, 46, 48, 50, 51, 54, 56, 61, 62, 66, 69–71, 74, 77). Regarding neuro-psychomotor development, all 15 papers reported motor, cognitive, or language delay (10, 11, 15, 17, 18, 24, 32, 33, 44, 47, 52, 58, 61, 62, 65). Noteworthy is that, in one paper, the authors reported autism spectrum disorder in three previously healthy children in the second year of life (11).
All studies that performed ophthalmological evaluations exposed some alteration, such as microphthalmia, fundoscopic alterations, macular atrophy, optic nerve abnormalities, strabismus and visual acuity defects (12, 14, 27, 36, 45, 50, 51, 56, 60, 61, 67, 68, 73–79). Twelve of 14 papers that evaluated audiological manifestations in children reported hearing disorders (11, 14, 27, 36, 37, 39, 43, 51, 56, 60, 62, 64) and two did not observe any abnormalities (30, 41).
Two papers reported unilateral diaphragmatic paralysis (45, 57), and another two found echocardiographic abnormalities (49, 61). These abnormalities were characterized by dilatation of the right atrium and the right ventricle, demonstrating an overload of the right heart chambers. In a study of children with Zika-related microcephaly, adenoid hypertrophy and symptoms of respiratory obstruction were reported (40).
Regarding genitourinary characteristics, studies reported neurogenic bladder and cryptorchidism (22, 23, 72). The most common orthopedic alteration was arthrogryposis (12, 16, 21, 36, 42, 46, 57). All papers that evaluated gastrointestinal manifestations reported dysphagia (38, 46, 48, 61). Regarding the nutritional status of children exposed to antenatal ZIKV, nine papers found anthropometric alterations such as low birth weight and growth retardation (14, 20, 21, 28, 29, 33, 48, 50, 63, 66) and one study observed endocrine dysfunctions in children with Zika-related microcephaly (75).
Discussion
In this section we discuss the main results of manuscripts selected for this systematic review to assess the main potential clinical alterations described in antenatally ZIKV-exposed children to date.
Neurologic, Neuroimaging and Neurodevelopmental Findings
Concerning clinical imaging alterations, (16, 34, 53, 59), severe brain damage was reported in CNS imaging studies in most children with antenatal exposure to ZIKV. The most common features identified were brain calcifications at the junction between cortical and subcortical white matter; these were associated with malformations of cortical development, usually with a simplified gyrus pattern and a predominance of pachygyria or polymicrogyria in the frontal lobes. Studies also identified an increased/dilated cisterna magna, corpus callosum abnormalities (which could be either hypoplasia or hypogenesis), ventriculomegaly, delayed myelination, and hypoplasia of the brain stem and/or cerebellum.
Petribu et al. (53) observed an interesting finding in that brain calcifications in children with confirmed or presumed CZS tended to decrease over time. This implies that brain calcifications should not be considered essential for diagnosis of CZS in children who present late to medical attention. Decrease in brain calcifications over time, however, was not associated with clinical improvement.
Santana et al. (61) reported that all children in their cohort had microcephaly, spasticity, and delayed neurological development. Epilepsy was found in 15 of 18 cases (83%). In a case series, Van Der Linden et al. (70) observed dystonic postures and other frequent and potentially disabling extrapyramidal signs. The study emphasized that early identification of extrapyramidal findings may help recognize neurodevelopmental problems and assist with implementation of rehabilitation, potentially influencing better strategies for rehabilitative interventions.
When analyzing sleep disorders in their cross-sectional study, Pinato et al. (54) showed that the CZS group of children had a shorter total sleep time and night sleep duration than the control group. However, no correlation was found between age and sleep patterns.
In a series of cases that assessed infants exposed to congenital ZIKV who were asymptomatic at birth, neurodevelopmental delay was identified through the use of the Bayley-III scale assessment tool (52). The abnormalities occurred mainly in the language domain during the first two years of life. The Z-score of the head circumference was significantly lower in the group with developmental delay, with the simultaneous presence of neurological abnormalities, which indicates a possible action of ZIKV infection in the developing brain (24).
Nielsen-Saines et al. (11) observed that, among the children evaluated by Bayley-III, 12% scored below two standard deviations (i.e., a score <70; a score of 100 ± 2 SD is the variation) in at least one functional domain; 28% of children scored between −1 and −2 SD in any domain (scores <85–70). Language function was most affected, with 35% of 146 children being below average. The authors described that neurodevelopmental outcomes were improved in female children, term babies, children with normal eye exames, and whose mothers were infected with ZIKV later in pregnancy. Mulkey et al. (47) found that infants with in utero ZIKV exposure without features of CZS were also at risk for abnormal neurodevelopment in the first 18 months of life.
Eye Findings
Regarding ophthalmological findings, studies (12, 26, 67, 68, 73, 74, 76, 78–80) found an association between congenital infection due to presumed exposure to ZIKV and macular lesions, macular circumscribed chorio-retinal atrophy, focal-spotted retinal pigment epithelium, optic nerve pallor, early-onset strabismus, nystagmus, and low visual acuity. Also, ocular involvement (macular and eye fundus abnormalities) in babies with presumed congenital ZIKV infection was most frequently observed in babies with a smaller head circumference at the time of birth and whose mothers were infected in the first trimester of pregnancy (73).
Hearing Deficits
Of the papers that assessed audiological function, the main findings were a statistically significant increase in latencies of waves I and III, compared to wave V, absence of otoacoustic emissions, and sensorineural hearing loss (37, 43). In most hearing loss cases associated with congenital infections, damage to the auditory system is due to cochlear involvement (81). Similar injuries are likely to be responsible for hearing loss in children with congenital ZIKV infection, although histological studies need to confirm this (39).
In a cross-sectional study, when evaluating 45 children with a mean age of 10 months, Leite et al. (41) found no association between exposure to ZIKV during pregnancy and audiological alterations. Similarly, when comparing children exposed and not exposed to ZIKV, Fandiño-Cárdenas et al. (30), in their cohort study of 66 exposed children did not observe hearing loss in the first two years of life.
In conclusion, hearing loss due to congenital ZIKV can be sensorineural, neural, conductive, isolated, or mixed. Therefore, a complete hearing assessment should be performed on all ZIKV-infected patients to rule out auditory neuropathy syndrome and sensorineural hearing loss (82).
Cardiac Findings/Congenital Heart Disease
When analyzing the cardiovascular system of ZIKV-exposed children, Santana et al. (61) found echocardiographic abnormalities suggesting tropism of ZIKV to tissue beyond the central nervous system. Corroborating this finding, Orofino et al. (49) found a higher frequency of cardiac alterations in ZIKV-exposed babies than in the general population. However, none of these defects were severe. Therefore, the authors suggested that recommendations for performance of fetal echocardiograms in women with ZIKV infection during pregnancy and recommendations for postnatal infant echocardiogram should follow general infant population guidelines.
Genito-Urinary Findings
All studies concerning genitourinary characteristics were performed in Brazil, two in the state of Rio de Janeiro and one in Pernambuco. Costa Monteiro et al. (22, 23) found that more than 90% of children with microcephaly in their series had neurogenic bladder, a health condition known to cause kidney damage when left untreated. On this theme, de Vasconcelos et al. (72) published a case series describing cryptorchidism in 3-year-old children with ZIKV-related microcephaly.
Nutrition, Gastro-Intestinal Findings and Feeding Difficulties
Regarding the nutritional status of children exposed to ZIKV, nine papers described anthropometric changes such as low birth weight and growth restriction (20, 21, 28, 29, 33, 48, 50, 66).
In a cohort study, Soares et al. (63) found differences in arm and arm muscle circumference and fat-free mass in children from 1 to 3 months of age. Weight and length at 3 months of age were lower in ZIKV-exposed infants. Similarly, Carvalho-Sauer et al. (20) concluded that low birth weight in children with CZS was 4-fold greater as compared to children without CZS. Furthermore, prematurity and cesarean delivery were associated with low birth weight in exposed children. It should also be noted that most children with CZS were born to mothers of African heritage, single, and with less years of education, suggesting CZS disproportionately affected disenfranchised populations (28, 63).
Leal et al. (38) described a delay in the initial pharyngeal phase of swallowing. This combined with significant oral dysfunction, increases the risk of oral aspiration, predominantly with liquid foods. Also, Santana et al. (61) reported that four of 18 patients who had swallowing impairment were fed by gastrostomy.
In addition, Leal et al. (40) in a cross-sectional study nested in a cohort study, found a high prevalence of adenoid hypertrophy in children with Zika-related microcephaly, with consequent upper airway obstruction leading to chronic upper airway obstructive disorder, secretory otitis media and subsequent dysphagia (40). Abdominal imaging studies on the other hand showed no characteristic findings that were higher than those observed in the general population (55).
Musculo-Skeletal Findings
Regarding orthopedic abnormalities, all seven papers described the presence of arthrogryposis in children with congenital zika, often present in both upper and lower extremities. A study by Aragão et al. (16) found that 75% of children with microcephaly and 100% of those with arthrogryposis had reduced thickness of the thoracic spinal cord. However, the latter group had evidence of narrowing of the entire spinal cord, with severely reduced spinal cord anterior roots. The authors concluded that it is crucial to consider Zika virus infection in the differential diagnosis of congenital diseases of the spinal cord and anterior nerve root if mother-infant pair have any risk factors for ZIKV antenatal exposure. This is especially relevant in mild cases where microcephaly is absent, and the only clinical manifestation is, for example, abnormal joints. On the other hand, health professionals should pay close attention when monitoring children from an epidemic area with mild or no clinical signs of spinal cord and anterior nerve root lesions, as they may have future problems with neuro-psychomotor development.
Endocrinologic Findings
Regarding the endocrine system, the most prevalent and clinically relevant problems were pubertal dysfunctions, thyroid disease, growth faltering and obesity. These conditions require careful monitoring and highlight the need for endocrine evaluations in children with CZS, particularly those with microcephaly. Early diagnosis and referral to appropriate treatment in this situation may often be necessary (75).
Need for Long Term Follow-Up
The repercussions of maternal infection during pregnancy on child development have been extensively described in the literature in regards to classic teratogenic pathogens responsible for TORCH syndromes (26). Fetal infection often triggers a systemic inflammatory response which may persist after birth, compounding further damage to the brain. This is one of the prevailing hypotheses on the pathogenesis of brain injury (26). Lesions associated with deep gray matter injury, vascular compromise and neural progenitor cell dysfunction have also been described (83–85).
Saad et al. (86) made the same recommendation in reviewing the most frequent clinical findings in children born to women with confirmed ZIKV infection during pregnancy. They described a broad spectrum of abnormalities resulting from an inflammatory reaction to the virus or a direct effect of the virus itself, causing damage to the CNS and neurological abnormalities which potentially manifest over time.
These published results describing developmental delay and other neuro-sensory deficits which may manifest later in life point to the need for continued monitoring of children with antenatal ZIKV exposure to assess risks of learning and behavioral disorders in the long term (85).
Conclusion
In this systematic review, the most relevant findings were injuries to the infant central nervous system. CZS is a neurotropic disease with several associated abnormalities. Although the majority of published studies were from Brazil, there were no regional differences across the country and also in comparison to other countries in Latin America. Another important finding which the studies underscored is the later delay in development that may subsequently occur in an apparently normal infant at the time of birth. Finally, due to the vulnerability of women and children and the severe repercussions of ZIKV infection in pregnancy, studies should continue to monitor these children as they age. Broader descriptions of clinical findings are also important to further characterize the spectrum of disease in children. Prospective studies evaluating infants and children with antenatal ZIKV exposure may be able to describe the actual prevalence of adverse pregnancy, infant and childhood outcomes in this population. Prompt recognition of clinical abnormalities allows for implementation of early interventions which can improve later neurodevelopmental pathways in children born to mothers with gestational ZIKV infection.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.
Author contributions
YA, JM, and PGB did the manuscript search, reviewed all the literature and drafted the paper, and approved the final text. PB, KN-S, and MM formulated the research question, performed the analysis and draft of the paper, and approved the final text. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by the Fiocruz PIP/IFF program, CNPq 441098/2016-9 and 305090/2016-0 grants; Faperj E_18/2015TXB; Wellcome Trust & the United Kingdoms Department for International Development (205377/Z/16/Z) grants; European Unions Horizon 2020 research and innovation programme under ZikaPLAN grant agreement no. 734584, RO1/AI140718 (NIH/NIAID) research grant. The role the funders was to pay for retrieval of manuscripts that were not open access and provide student scholarships (YA, PGB, and JM).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor declared to have joint publications with the authors PB, KN-S, and MM.
- ASD
autism spectrum disorder
- BVS
biblioteca virtual em saude – (virtual health library)
- CAPES
coordenação de aperfeiçoamento de pessoal de nível superior (thesis repository)
- CNS
central nervous system
- CZS
congenital zika syndrome
- PRISMA
preferred reporting items for systematic reviews
- SD
standard deviation
- TORCH
toxoplasmosis, rubella, cytomegalovirus, herpes simplex
- ZIKV
zika virus.
Abbreviations
References
1.
BasuRTumbanE. Zika virus on a spreading spree: what we now know that was unknown in the 1950's. Virol J. (2016) 13:165. 10.1186/s12985-016-0623-2
2.
WongSS-YPoonRW-SWongSC-Y. Zika virus infection—the next wave after dengue?J Form Med Assoc. (2016) 115:226–42. 10.1016/j.jfma.2016.02.002
3.
Oliveira MeloASMalingerGXimenesRSzejnfeldPOAlves SampaioSBispo de FilippisAM. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg?: physician alert. Ultrasound Obstet Gynecol. (2016) 47:6–7. 10.1002/uog.15831
4.
FrançaGVASchuler-FacciniLOliveiraWKHenriquesCMPCarmoEHPediVDet al. Congenital zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation. Lancet. (2016) 388:891–7. 10.1016/S0140-6736(16)30902-3
5.
BrasilPPereiraJPMoreiraMERibeiro NogueiraRMDamascenoLWakimotoMet al. Zika virus infection in pregnant women in rio de janeiro. N Engl J Med. (2016) 375:2321–34. 10.1056/NEJMoa1602412
6.
Brasil, Ministerio da Saúde (MS). Protocolo de Atendimento: Mulheres em Idade Fértil, Gestantes, Puérperas e Bebês Com Microcefalia. (2015). Available online at: https://bvsms.saude.gov.br/bvs/publicacoes/protocolo_resposta_microcefalia_relacionada_infeccao_virus_zika.pdf (accessed January 25, 2021).
7.
GullandA. Zika virus may be linked to several birth defects, expert warns. BMJ. (2016) 352:i1322. 10.1136/bmj.i1322
8.
Carvalho A deJALemosSMAGoulart LMH deF. Desenvolvimento da linguagem e sua relação com comportamento social, ambientes familiar e escolar: revisão sistemática. CoDAS. (2016) 28:470–9. 10.1590/2317-1782/20162015193
9.
DeThorneLS. Rethinking environmental influences on child language development. J Commun Dis. (2015) 57:1–2. 10.1016/j.jcomdis.2015.09.002
10.
Lopes MoreiraMENielsen-SainesKBrasilPKerinTDamascenoLPoneMet al. Neurodevelopment in infants exposed to zika virus in utero. N Engl J Med. (2018) 379:2377–9. 10.1056/NEJMc1800098
11.
Nielsen-SainesKBrasilPKerinTVasconcelosZGabagliaCRDamascenoLet al. Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children. Nat Med. (2019) 25:1213–7. 10.1038/s41591-019-0496-1
12.
ZinAATsuiIRossettoJVasconcelosZAdachiKValderramosSet al. Screening criteria for ophthalmic manifestations of congenital zika virus infection. JAMA Pediatr. (2017) 171:847. 10.1001/jamapediatrics.2017.1474
13.
MoherDLiberatiATetzlaffJAltmanDGThe PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. (2009) 6:e1000097. 10.1371/journal.pmed.1000097
14.
AlmeidaIMLMde RamosCVRodriguesDCde SousaACNascimentoM de LCAPC doda SilvaMVBet al. Aspectos clínicos e epidemiológicos da microcefalia no Estado do Piauí, Nordeste do Brasil, 2015-2016. J Pediatr. (2019) 95:466–74. 10.1016/j.jped.2018.04.013
15.
AlvesLVParedesCESilvaGCMelloJGAlvesJG. Neurodevelopment of 24 children born in Brazil with congenital Zika syndrome in 2015: a case series study. BMJ Open. (2018) 8:e021304. 10.1136/bmjopen-2017-021304
16.
AragaoMFVVBrainer-LimaAMHolandaACvan der LindenVVascoAragão LSilvaJúnior MLMet al. Spectrum of spinal cord, spinal root, and brain MRI abnormalities in congenital zika syndrome with and without arthrogryposis. AJNR Am J Neuroradiol. (2017) 38:1045–1053. 10.3174/ajnr.A5125
17.
BertolliJAttellJERoseCMooreCAMeloFStaplesJEet al. Functional outcomes among a cohort of children in northeastern Brazil meeting criteria for follow-up of congenital Zika virus infection. Am J Trop Med Hyg. (2020) 102:955–63. 10.4269/ajtmh.19-0961
18.
CarvalhoABritesCMochidaGVenturaPFernandesALageMLet al. Clinical and neurodevelopmental features in children with cerebral palsy and probable congenital Zika. Brain Dev. (2019) 41:587–94. 10.1016/j.braindev.2019.03.005
19.
CarvalhoMDCGMiranda-FilhoD de Bvan der LindenVSobralPFRamosRCFRochaMÂWet al. Sleep EEG patterns in infants with congenital Zika virus syndrome. Clin Neurophysiol. (2017) 128:204–14. 10.1016/j.clinph.2016.11.004
20.
Carvalho-SauerRCosta M daCNBarretoFRTeixeiraMG. Congenital Zika syndrome: prevalence of low birth weight and associated factors. Bahia, 2015–2017. Int J Infect Dis. (2019) 82:44–50. 10.1016/j.ijid.2019.02.040
21.
Contreras-CapetilloSNValadéz-GonzálezNManrique-SaidePCarcaño-CastilloREPacheco-TugoresFBarrera-PérezHAMet al. Birth defects associated with congenital zika virus infection in mexico. Clin Pediatr. (2018) 57:927–36. 10.1177/0009922817738341
22.
Costa MonteiroLMCruz GN deOFontesJMde AraujoGFVenturaTMonteiroACet al. Neurogenic bladder in the settings of congenital Zika syndrome: a confirmed and unknown condition for urologists. J Pediatr Urol. (2019) 15:450.e1-450.e7. 10.1016/j.jpurol.2019.06.021
23.
Costa MonteiroLMCruz GN deOFontesJMSaad SallesTRDBoechatMCBMonteiroACet al. Neurogenic bladder findings in patients with congenital Zika syndrome: a novel condition. PLoS ONE. (2018) 13:e0193514. 10.1371/journal.pone.0193514
24.
CranstonJSTieneSFNielsen-SainesKVasconcelosZPoneMVPoneSet al. Association between antenatal exposure to Zika virus and anatomical and neurodevelopmental abnormalities in children. JAMA Netw Open. (2020) 3:e209303. 10.1001/jamanetworkopen.2020.9303
25.
de Fatima Vasco AragaoMvan der LindenVBrainer-LimaAMCoeliRRRochaMASobral da SilvaPet al. Clinical features and neuroimaging (CT and MRI) findings in presumed Zika virus related congenital infection and microcephaly: retrospective case series study. BMJ. (2016) 353:i1901. 10.1136/bmj.i1901
26.
de Paula FreitasBde Oliveira DiasJRPrazeresJSacramentoGAKoAIMaiaMet al. Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in salvador, Brazil. JAMA Ophthalmol. (2016) 134:529. 10.1001/jamaophthalmol.2016.0267
27.
de Paula GuimarãesCMacedoMSBarbosaMAMarquesSMCostaPSde OliveiraÊC. Clinical findings in congenital infection by Zika virus: a retrospective study in a reference hospital in central-west Brazil. BMC Pediatr. (2019) 19:389. 10.1186/s12887-019-1762-6
28.
dos SantosSFMSoaresFVMde AbranchesADda CostaACCGomes-JúniorSC dos SFonseca V deMet al. Nutritional profile of newborns with microcephaly and factors associated with worse outcomes. Clinics. (2019) 74:e798. 10.6061/clinics/2019/e798
29.
dos SantosSFMSoaresFVMde AbranchesADda CostaACCMoreiraMELde Matos FonsecaV. Infants with microcephaly due to ZIKA virus exposure: nutritional status and food practices. Nutr J. (2019) 18:4. 10.1186/s12937-019-0429-3
30.
Fandiño-CárdenasMIdrovoAJVelandiaRMolina-FrankyJAlvarado-SocarrasJL. Zika virus infection during pregnancy and sensorineural hearing loss among children at 3 and 24 months post-partum. J Trop Pediatr. (2019) 65:328–35. 10.1093/tropej/fmy055
31.
FelixAHalletEFavreAKom-TchameniRDefoAFléchellesOet al. Cerebral injuries associated with Zika virus in utero exposure in children without birth defects in french guiana: case report. Medicine. (2017) 96:e9178. 10.1097/MD.0000000000009178
32.
FerreiraHSchiaritiVRegaladoISousaKPereiraSFechineCet al. Functioning and disability profile of children with microcephaly associated with congenital zika virus infection. IJERPH. (2018) 15:1107. 10.3390/ijerph15061107
33.
FrançaTMedeirosWSouzaNLongoEPereiraSFrançaTet al. Growth and development of children with microcephaly associated with congenital Zika virus syndrome in Brazil. IJERPH. (2018) 15:1990. 10.3390/ijerph15091990
34.
JucáEPessoaARibeiroEMenezesRKerbageSLopesTet al. Hydrocephalus associated to congenital zika syndrome: does shunting improve clinical features?Childs Nerv Syst. (2018) 34:101–6. 10.1007/s00381-017-3636-2
35.
KandaPAMAguiar A deAXMirandaJLFalcaoALAndradeCSReis LN dosSet al. Sleep EEG of microcephaly in Zika outbreak. Neurodiag J. (2018) 58:11–29. 10.1080/21646821.2018.1428461
36.
C. LageM-LCarvalhoAVenturaPTaguchiTFernandesAPinhoSet al. Clinical, neuroimaging, and neurophysiological findings in children with microcephaly related to congenital zika virus infection. IJERPH. (2019) 16:309. 10.3390/ijerph16030309
37.
LealMCMunizLFFerreiraTSASantosCMAlmeidaLCVan Der LindenVet al. Hearing loss in infants with microcephaly and evidence of congenital Zika virus infection — Brazil, November 2015–May 2016. MMWR Morb Mortal Wkly Rep. (2016) 65:917–9. 10.15585/mmwr.mm6534e3
38.
LealMCvan der LindenVBezerraTPde ValoisLBorgesACGAntunesMMCet al. Characteristics of dysphagia in infants with microcephaly caused by congenital Zika virus infection, Brazil, 2015. Emerg Infect Dis. (2017) 23:1253–9. 10.3201/eid2308.170354
39.
Leal M deCMunizLFCaldasNeto S da Svan der LindenVRamosRCFLeal M deCet al. Sensorineural hearing loss in a case of congenital Zika virus. Braz J Otorhinolaryngol. (2020) 86:513–5. 10.1016/j.bjorl.2016.06.001
40.
LealMCSeabra RamosDPinto BezerraTVilelaAESCMaciel RJ deFRodriguesMet al. The prevalence of adenoid hypertrophy among children with Zika related microcephaly. Viruses. (2021) 13:62. 10.3390/v13010062
41.
LeiteRFPSantosMSARibeiroEMPessoaALSLewisDRGiachetiCMet al. Triagem auditiva de crianças com síndrome congênita pelo vírus Zika atendidas em Fortaleza, Ceará, 2016. Epidemiol Serv Saúde. (2018) 27:e2017553. 10.5123/S1679-49742018000400002
42.
LindenVLinsOGPetribuNCMeloACMGMooreJRasmussenSAet al. Diaphragmatic paralysis: evaluation in infants with congenital Zika syndrome. Birth Defec Res. (2019) 111:1577–83. 10.1002/bdr2.1597
43.
Marques AbramovDSaadTGomes-JuniorS-Cde Souza e SilvaDAraújoILopes MoreiraMEet al. Auditory brainstem function in microcephaly related to Zika virus infection. Neurology. (2018) 90:e606–14. 10.1212/WNL.0000000000004974
44.
MeloAGamaGLDa Silva JúniorRADe AssunçãoPLTavaresJSDa SilvaMBet al. Motor function in children with congenital Zika syndrome. Dev Med Child Neurol. (2020) 62:221–6. 10.1111/dmcn.14227
45.
Meneses J doAIshigamiACde MelloLMde AlbuquerqueLLde BritoCAACordeiroMTet al. Lessons learned at the epicenter of brazil's congenital zika epidemic: evidence from 87 confirmed cases. Clin Infect Dis. (2017) 64:1302–8. 10.1093/cid/cix166
46.
Moura da SilvaAAGanzJSSSousa P daSDoriquiMJRRibeiroMRCBranco M dosRFCet al. Early growth and neurologic outcomes of infants with probable congenital zika virus syndrome. Emerg Infect Dis. (2016) 22:1953–6. 10.3201/eid2211.160956
47.
MulkeySBArroyave-WesselMPeytonCBulasDIFourzaliYJiangJet al. Neurodevelopmental abnormalities in children with in utero Zika virus exposure without congenital Zika syndrome. JAMA Pediatr. (2020) 174:269. 10.1001/jamapediatrics.2019.5204
48.
Oliveira-FilhoJFelzemburghRCostaFNeryNMattosAHenriquesDFet al. Seizures as a complication of congenital zika syndrome in early infancy. Am J Trop Med Hyg. (2018) 98:1860–2. 10.4269/ajtmh.17-1020
49.
OrofinoDHGPassosSRLde OliveiraRVCFariasCVBLeite M deFMPPoneSMet al. Cardiac findings in infants with in utero exposure to Zika virus- a cross sectional study. PLoS Negl Trop Dis. (2018) 12:e0006362. 10.1371/journal.pntd.0006362
50.
OspinaMLTongVTGonzalezMValenciaDMercadoMGilboaSMet al. Zika virus disease and pregnancy outcomes in colombia. N Engl J Med. (2020) 383:537–45. 10.1056/NEJMoa1911023
51.
PachecoONewtonSMDazaMCatesJERealesJAMBurkelVKet al. Neurodevelopmental findings in children 20-30 months of age with postnatal Zika infection at 1-12 months of age, Colombia, September-November 2017. Paediatr Perinat Epidemiol. (2020) 35:92–7. 10.1111/ppe.12690
52.
PeçanhaPMGomes JuniorSCPoneSMPone MV daSVasconcelosZZinAet al. Neurodevelopment of children exposed intra-uterus by Zika virus: a case series. PLoS ONE. (2020) 15:e0229434. 10.1371/journal.pone.0229434
53.
Petribu NC deLAragao M deFVvan der LindenVParizelPJungmannPAraújoLet al. Follow-up brain imaging of 37 children with congenital Zika syndrome: case series study. BMJ. (2017) 359:j4188. 10.1136/bmj.j4188
54.
PinatoLRibeiroEMLeiteRFPLopesTFPessoaALSGuissoni CamposLMet al. Sleep findings in Brazilian children with congenital Zika syndrome. Sleep. (2018) 41:1–7. 10.1093/sleep/zsy009
55.
Pone MV daS. Contribuições Para o Conhecimento Sobre a Infecção Pelo Zika Vírus: a) Papel da USG Abdominal no Exame da Criança Exposta e b) Detecção Prolongada do Vírus em Adultos Não Grávidos. (2016). Available online at: https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=4439383 (accessed October 14, 2020).
56.
PoolK-LAdachiKKarnezisSSalamonNRomeroTNielsen-SainesKet al. Association between neonatal neuroimaging and clinical outcomes in zika-exposed infants from rio de Janeiro, Brazil. JAMA Netw Open. (2019) 2:e198124. 10.1001/jamanetworkopen.2019.8124
57.
RajapakseNSEllsworthKLiesmanRMHoMLHenryNTheelESet al. Unilateral phrenic nerve palsy in infants with congenital Zika syndrome. Emerg Infect Dis. (2018) 24:1422–7. 10.3201/eid2408180057
58.
RiceMEGalangRRRothNMEllingtonSRMooreCAValencia-PradoMet al. Vital signs: Zika-associated birth defects and neurodevelopmental abnormalities possibly associated with congenital zika virus infection — U.S. Territories and freely associated states, 2018. MMWR Morb Mortal Wkly Rep. (2018) 67:858–67. 10.15585/mmwr.mm6731e1
59.
RochaSGMOCorreiaLLda CunhaAJLARochaHALLeiteÁJMCamposJSet al. Zika virus infection and microcephaly: a case-control study in Brazil. Ann Glob Health. (2019) 85:116. 10.5334/aogh.2394
60.
RomaJHFAlvesRCda SilvaVSFerreiraMJde AraújoCPavoniJHCet al. Descriptive study of suspected congenital Zika syndrome cases during the 2015-2016 epidemic in Brazil. Rev Soc Bras Med Trop. (2019) 52:e20190105. 10.1590/0037-8682-0105-2019
61.
SantanaMBLamasCCAthaydeJGCalvetGMoreiraJDe LorenzoA. Congenital Zika syndrome: is the heart part of its spectrum?Clin Microbiol Infect. (2019) 25:1043–4. 10.1016/j.cmi.2019.03.020
62.
Satterfield-NashAKotzkyKAllenJBertolliJMooreCAPereiraIOet al. Health and development at age 19–24 months of 19 children who were born with microcephaly and laboratory evidence of congenital zika virus infection during the 2015 Zika virus outbreak — Brazil, 2017. MMWR Morb Mortal Wkly Rep. (2017) 66:1347–51. 10.15585/mmwr.mm6649a2
63.
SoaresFAbranchesADVillelaLLaraSAraújoDNehabSet al. Zika virus infection in pregnancy and infant growth, body composition in the first three months of life: a cohort study. Sci Rep. (2019) 9:19198. 10.1038/s41598-019-55598-6
64.
Soriano-ArandesAFrickMAGarcíaLópez-Hortelano MSulleiroERodóCSánchez-SecoMPet al. Clinical outcomes of a Zika virus mother–child pair cohort in Spain. Pathogens. (2020) 9:352. 10.3390/pathogens9050352
65.
SubissiLDubTBesnardMMariteragi-HelleTNhanTLutringer-MagninDet al. Zika virus infection during pregnancy and effects on early childhood development, french polynesia, 2013–2016. Emerg Infect Dis. (2018) 24:1850–8. 10.3201/eid2410.172079
66.
SulleiroEFrickMARodóCEspasaMThorneCEspiauMet al. The challenge of the laboratory diagnosis in a confirmed congenital Zika virus syndrome in utero: a case report. Medicine. (2019) 98:e15532. 10.1097/MD.0000000000015532
67.
TrigueiroSANevesBFAguiar deMSBAraújode JSS. Correlation between cephalic circumference at birth and ocular alterations in patients with microcephaly potentially associated with Zika Virus infection. Rev Assoc Med Bras. (2019) 65:909–13. 10.1590/1806-9282.65.6.909
68.
TsuiIMoreiraMELRossettoJDVasconcelosZGawSLNevesLMet al. Eye findings in infants with suspected or confirmed antenatal zika virus exposure. Pediatrics. (2018) 142:e20181104. 10.1542/peds.2018-1104
69.
van der LindenHSilveira-MoriyamaLvan der LindenVPessoaAValenteKMinkJet al. Movement disorders in children with congenital Zika virus syndrome. Brain Dev. (2020) 42:720–9. 10.1016/j.braindev.2020.06.016
70.
van der LindenVFilhoELRLinsOGvan der LindenAAragãoM de FVVBrainer-LimaAMet al. Congenital Zika syndrome with arthrogryposis: retrospective case series study. BMJ. (2016) 354:i3899. 10.1136/bmj.i3899
71.
van der LindenVPessoaADobynsWBarkovichAJJúniorHvan derLFilhoELRet al. Description of 13 infants born during October 2015–January 2016 with congenital Zika virus infection without microcephaly at birth — Brazil. MMWR Morb Mortal Wkly Rep. (2016) 65:1343–8. 10.15585/mmwr.mm6547e2
72.
de VasconcelosRALXimenesRAACaladoAAMartelliCMTGonçalvesAVBrickleyEBet al. Cryptorchidism in children with Zika-related microcephaly. Am J Trop Med Hyg. (2020) 102:982–4. 10.4269/ajtmh.19-0753
73.
VenturaCVMaiaMTravassosSBMartinsTTPatriotaFNunesMEet al. Risk factors associated with the ophthalmoscopic findings identified in infants with presumed Zika virus congenital infection. JAMA Ophthalmol. (2016) 134:912. 10.1001/jamaophthalmol.2016.1784
74.
VenturaLOVenturaCVDias N deCVilarIGGoisALArantesTEet al. Visual impairment evaluation in 119 children with congenital Zika syndrome. J Am Assoc Pediatric Ophthalmol Strab. (2018) 22:218–22.e1. 10.1016/j.jaapos.2018.01.009
75.
Veras GonçalvesAMiranda-FilhoD de BRocha VilelaLCRamosRCFde AraújoTVBde VasconcelosRALet al. Endocrine dysfunction in children with zika-related microcephaly who were born during the 2015 epidemic in the state of pernambuco, Brazil. Viruses. (2020) 13:1. 10.3390/v13010001
76.
VerçosaICarneiroPVerçosaRGirãoRRibeiroEMPessoaAet al. The visual system in infants with microcephaly related to presumed congenital Zika syndrome. J Am Assoc Pediatr Ophthalmol Strab. (2017) 21:300–4.e1. 10.1016/j.jaapos.2017.05.024
77.
WalkerCLEhingerNMasonBOlerELittleM-TEOhumaEOet al. Ultrasound prediction of Zika virus-associated congenital injury using the profile of fetal growth. PLoS ONE. (2020) 15:e0233023. 10.1371/journal.pone.0233023
78.
ZinAATsuiIRossettoJDGawSLNevesLMZinOAet al. Visual function in infants with antenatal Zika virus exposure. J Am Assoc Pediatr Ophthalmol Strab. (2018) 22:452–6.e1. 10.1016/j.jaapos.2018.07.352
79.
VenturaLOVenturaCVLawrenceLvan der LindenVvan der LindenAGoisALet al. Visual impairment in children with congenital Zika syndrome. J Am Assoc Pediatr Ophthalmol Strab. (2017) 21:295–9.e2. 10.1016/j.jaapos.2017.04.003
80.
PaulAMAcharyaDNeupaneBThompsonEAGonzalez-FernandezGCopelandKMet al. Congenital Zika virus infection in immunocompetent mice causes postnatal growth impediment and neurobehavioral deficits. Front Microbiol. (2018) 9:2028. 10.3389/fmicb.2018.02028
81.
WuY-HCuiX-YYangWFanD-YLiuDWangP-Get al. Zika virus infection in hypothalamus causes hormone deficiencies and leads to irreversible growth delay and memory impairment in mice. Cell Rep. (2018) 25:1537–47.e4. 10.1016/j.celrep.2018.10.025
82.
SaadTPennaeCostaAAdeGóes FVde FreitasMde AlmeidaJVde Santa IgnêzLJet al. Neurological manifestations of congenital Zika virus infection. Childs Nerv Syst. (2018) 34:73–8. 10.1007/s00381-017-3634-4
83.
CohenBEDurstenfeldARoehmPC. Viral causes of hearing loss: a review for hearing health professionals. Trends Hearing. (2014) 18:2331216514541361. 10.1177/2331216514541361
84.
KapogiannisBGChakhtouraNHazraRSpongCY. Bridging knowledge gaps to understand how zika virus exposure and infection affect child development. JAMA Pediatr. (2017) 171:478. 10.1001/jamapediatrics.2017.0002
85.
Adams WaldorfKMMcAdamsRM. Influence of infection during pregnancy on fetal development. Reproduction. (2013) 146:R151–62. 10.1530/REP-13-0232
86.
MartinotAJAbbinkPAfacanOProhlAKBronsonRHechtJLet al. Fetal neuropathology in Zika virus-infected pregnant female rhesus monkeys. Cell. (2018) 173:1111–22.e10. 10.1016/j.cell.2018.03.019
Summary
Keywords
zika virus, systematic review, neurological repercussion, clinical repercussion, neurodevelopment
Citation
Amaral YNV, Malacarne J, Brandão PG, Brasil P, Nielsen-Saines K and Moreira MEL (2021) Time to Evaluate the Clinical Repercussions of Zika Virus Vertical Transmission? A Systematic Review. Front. Psychiatry 12:699115. doi: 10.3389/fpsyt.2021.699115
Received
22 April 2021
Accepted
30 July 2021
Published
30 August 2021
Volume
12 - 2021
Edited by
Peter B. Marschik, University Medical Center Göttingen, Germany
Reviewed by
Priya Soni, Cedars Sinai Medical Center, United States; Livia Rosa-Fernandes, University of Southern Denmark, Denmark
Updates
Copyright
© 2021 Amaral, Malacarne, Brandão, Brasil, Nielsen-Saines and Moreira.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Maria Elisabeth Lopes Moreira elisabeth.moreira@iff.fiocruz.br
This article was submitted to Child and Adolescent Psychiatry, a section of the journal Frontiers in Psychiatry
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.